EP2867245
Hreinsun ídúrónat-2-súlfatasa
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
28.6.2013EP published:
17.10.2018EP application number:
13809853.8
EP translation filed:
15.10.2018Grant published:
15.11.2018EPO information:
European Patent Register
Max expiry date:
27.6.2033Expiry date:
27.6.2025
Title:
PURIFICATION OF IDURONATE-2-SULFATASE
Timeline
Today
28.6.2013EP application
15.10.2018Translation submitted
17.10.2018EP Publication
15.11.2018Registration published
27.6.2025Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, JP
Inventor
Name:
NICHOLS, DaveAddress:
Lexington, Massachusetts, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261666733 PDate:
29.6.2012Country:
US
Classification
Categories:
C07K 1/00, C07K 16/00, A61K 38/17
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 21.5.2019
Expires: 27.6.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 8
Paid: 19.5.2020
Expires: 27.6.2021
Payer: Patice ehf.
Number: 9
Paid: 19.5.2021
Expires: 27.6.2022
Payer: Patice ehf.
Number: 10
Paid: 18.5.2022
Expires: 27.6.2023
Payer: Patice ehf.
Number: 11
Paid: 24.5.2023
Expires: 27.6.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 23.5.2024
Expires: 27.6.2025
Payer: Árnason Faktor ehf.